Physician profile
Samuel S Kim
NPI 1184771172
$221,256.83
in general payments reported to CMS, 2019-2025
17 companies · $29K in 2025
The $29K reported for 2025 was more than what 95% of Thoracic Surgery (Cardiothoracic Vascular Surgery) providers received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $79K · 2020: $28K · 2021: $20K · 2022: $28K · 2023: $18K · 2024: $20K · 2025: $29K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $48K · Travel and Lodging: $8,693 · Consulting Fee: $4,000 · Food and Beverage: $3,400 · Education: $2,500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $48,000.00 |
| Travel and Lodging | $8,693.47 |
| Consulting Fee | $4,000.00 |
| Food and Beverage | $3,400.29 |
| Education | $2,500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $216,606.50 | 2019-2025 | Da Vinci Sp, Da Vinci Surgical System |
| Ethicon INC. | $1,959.59 | 2021 | |
| Medical Device Business Services, INC. | $1,154.70 | 2023 | |
| Medtronic, INC. | $326.02 | 2021-2023 | Signia |
| Davol INC. | $181.87 | 2023 | Progel Applicator Spray Tips |
| Ethicon US, LLC | $171.29 | 2024-2025 | Monocryl, Prolene, Linx Reflux Management System |
| Astrazeneca Pharmaceuticals LP | $163.54 | 2024-2025 | |
| Bolton Medical INC | $153.32 | 2024 | Treo Abdominal Stent-Graft System |
| Baxter Healthcare | $132.60 | 2024 | Preveleak |
| Glaxosmithkline, LLC. | $100.21 | 2019 | |
| Pinnacle Biologics, INC | $84.19 | 2019 | |
| Becton, Dickinson and Company | $60.17 | 2019 | |
| Conmed Corporation | $45.45 | 2021 | |
| Nuvasive, INC. | $34.64 | 2021 | |
| Amgen INC. | $33.94 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $27.08 | 2025 | Teligen |
| Mauna Kea Technologies, INC. | $21.72 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samuel Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.